Bupropion Hydrochloride
- Product NDC
- 71335-0313
- 11-digit product format
- 713350313
- Labeler code
- 71335
- Product ID
- 71335-0313_e5b41311-e76d-447b-8ab5-451f6fcbb360
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA206556
- Marketing category
- ANDA
- Marketing start
- 2016-08-29
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0313-1 | 71335031301 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0313-1) | 2017-04-19 | 0000-00-00 | No | No | Current |
| 71335-0313-2 | 71335031302 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0313-2) | 2017-04-19 | 0000-00-00 | No | No | Current |
| 71335-0313-3 | 71335031303 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0313-3) | 2017-04-19 | 0000-00-00 | No | No | Current |
| 71335-0313-4 | 71335031304 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0313-4) | 2017-04-19 | 0000-00-00 | No | No | Current |
| 71335-0313-5 | 71335031305 | 8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-0313-5) | 2017-04-19 | 0000-00-00 | No | No | Current |